US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment - Reuters

Reuters

US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment Reuters

US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment Reuters

Ver fuente original → ← Volver a noticias